Authors:
Brunner, HI
Kim, KN
Ballinger, SH
Bowyer, SL
Griffin, TA
Higgins, GC
Mier, R
Passo, MH
Rennebohm, R
Schikler, K
Lovell, DJ
Citation: Hi. Brunner et al., Current medication choices in juvenile rheumatoid arthritis II - Update ofa survey performed in 1993, JCR-J CLIN, 7(5), 2001, pp. 295-300
Authors:
Huber, AM
Hicks, JE
Lachenbruch, PA
Perez, MD
Zemel, LS
Rennebohm, RM
Wallace, CA
Lindsley, CB
Passo, MH
Ballinger, SH
Bowyer, SL
Reed, AM
White, PH
Katona, IM
Miller, FW
Rider, LG
Feldman, BM
Citation: Am. Huber et al., Validation of the childhood health assessment questionnaire iu the juvenile idiopathic myopathies, J RHEUMATOL, 28(5), 2001, pp. 1106-1111
Authors:
Thompson, SD
Luyrink, LK
Graham, TB
Tsoras, M
Ryan, M
Passo, MH
Glass, DN
Citation: Sd. Thompson et al., Chemokine receptor CCR4 on CD4(+) T cells in juvenile rheumatoid arthritissynovial fluid defines a subset of cells with increased IL-4 : IFN-gamma mRNA ratios, J IMMUNOL, 166(11), 2001, pp. 6899-6906
Authors:
Hashkes, PJ
Balistreri, WF
Bove, KE
Ballard, ET
Passo, MH
Citation: Pj. Hashkes et al., The relationship of hepatotoxic risk factors and liver histology in methotrexate therapy for juvenile rheumatoid arthritis, J PEDIAT, 134(1), 1999, pp. 47-52
Authors:
Lovell, DJ
Lindsley, CB
Rennebohm, RM
Ballinger, SH
Bowyer, SL
Giannini, EH
Hicks, JE
Levinson, JE
Mier, R
Pachman, LM
Passo, MH
Perez, MD
Reed, AM
Schikler, KN
Smith, M
Zemel, LS
Rider, LG
Citation: Dj. Lovell et al., Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies - II. The Childhood Myositis Assessment Scale (CMAS): A quantitative tool for the evaluation of muscle function, ARTH RHEUM, 42(10), 1999, pp. 2213-2219